Skip to content

Effect of Goal-directed Hemodynamic Therapy on Short-term Postoperative Complications in Patients With Extensive Burns

Effect of Goal-directed Hemodynamic Therapy on Short-term Postoperative Complications in Patients With Extensive Burns: a Single-center Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05221788
Enrollment
100
Registered
2022-02-03
Start date
2020-01-01
Completion date
2021-12-01
Last updated
2022-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamics

Brief summary

To investigate the effect of goal-directed hemodynamic management on perfusion and short-term prognosis of patients undergoing scab grafting in early stage of extensive burns.

Detailed description

Objective: To investigate the effect of goal-directed hemodynamic management on perfusion and short-term prognosis of patients undergoing scab grafting in early stage of extensive burns. Methods: Ninety-five patients with extensive burns undergoing early debridement grafting were randomly divided into a standard hemodynamic management group (control group) and a goal-directed hemodynamic therapy group (GDHT group), with the control group guided by conventional parameters and the GDHT group guided by SV based on Vigileo. The primary outcome were incidence of cardiac complications, pulmonary complications, neurological disease, acute kidney injury, and pain within 7 days postoperatively. Secondary outcome included microcirculatory perfusion metrics: Lactate (lac), The central venous-arterial carbon dioxide partial pressure difference (Pcv-aCO2).

Interventions

Compounded sodium lactate 3 ml/kg/h was given intravenously as a basal rehydration volume before induction, and 200 ml of electrolyte solution was given after induction. If SV increased \>10%, 200 ml of electrolyte solution was continued until SV increased \<10%. After fluid shock, if SV increases \<10% but mean arterial pressure (MAP) \<65 mmHg and/or cardiac index (CI) \<2.5l/min/m2 give low-dose norepinephrine continuous pumping and/or dobutamine continuous pumping. If hypotension was accompanied by hypovolemia (defined as urine output \<0.5 ml /kg/h and/or heart rate more than 20% above baseline), plasma was administered until urine output and/or HR returned to normal. Fluid responsiveness and hemodynamic variables were reassessed at least every 15 minutes, and more frequently in cases of hemodynamic instability.

Sponsors

Guangzhou Red Cross Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. the age is between 18 and 65 years old; 2. the burn area ≥ 50% total burn surface area (TBSA) or the third degree wound area ≥ 20% TBSA; 3. patients will undergo the first operation after fluid resuscitation (after the shock period). The types of operation include incision decompression, escharectomy and skin grafting, and so on.

Exclusion criteria

1. Severe cardiac or pulmonary disease prior to the burn injury, combined with severe internal organ damage. 2. Patients or family members refusing informed consent for this study.

Design outcomes

Primary

MeasureTime frameDescription
postoperative pain conditionswithin 7 days postoperativelypostoperative pain
Incidence of pulmonary complicationswithin 7 days postoperativelyIncidence of pulmonary complications (pneumonia, pulmonary edema, pleural effusion, oxygenation index \<300)
Incidence of neurological complicationswithin 7 days postoperativelyIncidence of Neurological Disorders within 7 days postoperatively (Stroke and Delirium)
Incidence of acute kidney injurywithin 7 days postoperativelydefined by acute kidney injury criteria.
Incidence of cardiac complicationswithin 7 days postoperativelyIncidence of cardiac complications within 7 days of surgery (myocardial infarction (electrocardiogram (ECG) and/or troponin T serum concentration; new-onset atrial fibrillation)

Secondary

MeasureTime frameDescription
Blood lactatethe end of operation (T4)an indicator related to microcirculation perfusion
The central venous-arterial carbon dioxide partial pressure difference (Pcv-aCO2)before operation (T1)an indicator related to microcirculation perfusion
Blood lacatebefore operation (T1)an indicator related to microcirculation perfusion

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026